MX1 and COVID-19: Although the expression of MX1 and MX2 in patients with COVID-19 were significantly higher than those in non-COVID-19 groups, MX1 shows a greater positive correlation with patients with COVID-19 and may be more specific than MX2 in response to SARS-CoV-2.